Swiss All Share Index
17.970,97
PKT
-10,34
PKT
-0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.11.14 | Holcim buy | Deutsche Bank AG | |
| 06.11.14 | Holcim Sell | S&P Capital IQ | |
| 06.11.14 | Holcim buy | Deutsche Bank AG | |
| 06.11.14 | Holcim buy | Kepler Cheuvreux | |
| 05.11.14 | UBS Verkaufen | Bankhaus Lampe KG | |
| 05.11.14 | Holcim Neutral | BNP PARIBAS | |
| 05.11.14 | Holcim Neutral | BNP PARIBAS | |
| 05.11.14 | UBS Neutral | Credit Suisse Group | |
| 05.11.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.11.14 | Holcim buy | UBS AG | |
| 04.11.14 | Holcim Neutral | Credit Suisse Group | |
| 04.11.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 03.11.14 | Nestlé overweight | JP Morgan Chase & Co. | |
| 03.11.14 | Holcim buy | S&P Capital IQ | |
| 03.11.14 | Zurich Insurance Outperform | Credit Suisse Group | |
| 03.11.14 | UBS Sell | Société Générale Group S.A. (SG) | |
| 03.11.14 | Zurich Insurance Outperform | Credit Suisse Group | |
| 31.10.14 | Holcim buy | UBS AG | |
| 31.10.14 | Novartis Halten | Independent Research GmbH | |
| 30.10.14 | Nestlé Neutral | Citigroup Corp. | |
| 29.10.14 | UBS buy | Deutsche Bank AG | |
| 29.10.14 | Novartis Hold | Deutsche Bank AG | |
| 29.10.14 | UBS overweight | JP Morgan Chase & Co. | |
| 29.10.14 | UBS overweight | Morgan Stanley | |
| 29.10.14 | Swiss Re Neutral | UBS AG | |
| 28.10.14 | Novartis buy | S&P Capital IQ | |
| 28.10.14 | UBS Strong Buy | S&P Capital IQ | |
| 28.10.14 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 27.10.14 | UBS buy | Deutsche Bank AG | |
| 24.10.14 | UBS Equal-Weight | Morgan Stanley | |
| 24.10.14 | UBS Underweight | JP Morgan Chase & Co. | |
| 24.10.14 | ABB (Asea Brown Boveri) Outperform | Credit Suisse Group | |
| 24.10.14 | UBS Neutral | UBS AG | |
| 23.10.14 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 23.10.14 | Novartis buy | UBS AG | |
| 23.10.14 | UBS buy | S&P Capital IQ | |
| 23.10.14 | UBS neutral | Independent Research GmbH | |
| 23.10.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.10.14 | Holcim buy | Kepler Cheuvreux | |
| 22.10.14 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH |